AGENUS INC Investments, Fair Value Disclosure
AGENUS INC (AGEN) had Investments, Fair Value Disclosure of $0 as of 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:InvestmentsFairValueDisclosure · last filed 2018-03-16
- 2017-12-31: Investments, Fair Value Disclosure $0.00.
- 2017-09-30: Investments, Fair Value Disclosure $4.98M.
- 2017-06-30: Investments, Fair Value Disclosure $14.94M.
- 2017-03-31: Investments, Fair Value Disclosure $9.96M.
| Period end | Investments, Fair Value Disclosure |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-16 |
| 2017-09-30 | $4.98M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $14.94M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $9.96M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $4.99M 10-K · filed 2018-03-16 |
| 2016-09-30 | $19.96M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $49.90M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $69.90M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $34.97M 10-K · filed 2017-03-16 |
| 2015-09-30 | $14.99M 10-Q · filed 2015-11-04 |
| 2014-12-31 | $14.51M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |